March 14th, 2012

University of Minnesota, Mayo Project Wins Biotech Grant

By

The Minnesota Partnership for Biotechnology and Medical Genomics has awarded $1.35 million to University of Minnesota and Mayo Clinic researchers seeking new treatments for myelodysplastic syndrome (MDS), a cancer of the blood that impacts the way the human body develops blood cells. The grant will help support the development of pilot studies that could someday result…

 

Finance & Commerce by Chris Newmarker 3/14/12

Tags: Minnesota Partnership, Minnesota Partnership for Biotechnology and Medical Genomics, Myelodysplatic Syndrome, Research, University of Minnesota

Contact Us · Privacy Policy